Eucrates Biomedical Acquisition Corp.
Financial ratios & Valuation

Historical Multiples (2020 – 2022)

2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
15.73K34.345.3731.4532.90
Price/Sales ratio
N/AN/AN/AN/AN/A
Price/Book Value ratio
1.321.323.48-28.482.40
Price/Cash Flow ratio
N/A-261.61-47.22-185.57-223.59
Price/Free Cash Flow ratio
N/A-261.61-47.22-185.57-223.59
Price/Earnings Growth ratio
N/A0.000.110.000.00
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/A
Effective Tax Rate
N/A-0.93%-128.87%N/A-0.46%
Return on Assets
0.00%3.63%44.35%3.20%23.99%
Return On Equity
0.00%3.85%64.87%-78.73%34.36%
Return on Capital Employed
0.00%-0.70%-5.62%-0.75%-0.72%
Liquidity Ratios
Current Ratio
N/AN/AN/A0.81N/A
Quick Ratio
19.416.862.020.504.44
Cash ratio
10.471.270.280.500.88
Days of Sales Outstanding
N/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/A0.03N/A
Debt Equity Ratio
N/AN/AN/A-1.05N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A
Company Equity Multiplier
1.031.051.46-28.251.26
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
N/A1111
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/A